Successful islet transplantation from a single pancreas harvested from a young, low-BMI, non-heart-beating cadaver

被引:7
作者
Goto, T [1 ]
Tanioka, Y [1 ]
Sakai, T [1 ]
Matsumoto, I [1 ]
Kakinoki, K [1 ]
Tanaka, T [1 ]
Li, S [1 ]
Yoshikawa, T [1 ]
Fujino, Y [1 ]
Suzuki, Y [1 ]
Kuroda, Y [1 ]
机构
[1] Kobe Univ, Grad Sch Med, Div Gastroenterol Surg, Chuo Ku, Kobe, Hyogo 6500017, Japan
关键词
D O I
10.1016/j.transproceed.2005.09.041
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Young donors, donors with low body mass index (BMI), and non-heart-beating (NHB) donors are considered nonideal for islet transplantation. In this report, we successfully used a pancreas from a young, low-BMI, NHB donor for islet transplantation. Methods. The donor was a 15-year-old adolescent boy whose cause of death was rupture of a primary brain tumor. According to Japanese regulations, his pancreas was procured after cardiac arrest. Warm ischemic time was 3 minutes and cold ischemic time was 300 minutes. The pancreas was digested by the automated method of Ricordi, followed by purification using continuous Euro-Ficoll gradients on a Cobe 2991 device. The recipient was a 35-year-old woman with unstable type 1 diabetes mellitus. Her pretransplant C-peptide level was null. She suffered frequent hypoglycemic unawareness. Her pretransplant M value, which is a good marker for glucose instability, was 125. Islet yield was 252,816 IEQ. There were no signs of contamination. Viability of islets assessed by FDA/PI staining was 83%. Stimulation index was 2.7. Results. The patient received 5160 IEQ/kg of islets via the portal vein under local anesthesia. There were no transplant-related complications. Although she required minimal exogenous insulin, her C-peptide level increased to 0.7 ng/mL at postoperative day (POD) 14. Her M value at POD 15 to 19 decreased dramatically to 23.6, indicating good glycemic control. At 3 months posttransplant, episodes of hypoglycemia disappeared. Conclusions. Although an additional transplant is mandatory to wean patients from insulin, this case shows the possibility of using marginal donors, such as a young, low-BMI, NHB donor, for pancreas islet transplantation.
引用
收藏
页码:3430 / 3432
页数:3
相关论文
共 8 条
[1]  
DEAI T, 1999, KOBE J MED SCI, V26, P191
[2]  
KURODA Y, 1988, TRANSPLANTATION, V46, P457
[3]   Variables in organ donors that affect the recovery of human islets of langerhans [J].
Lakey, JRT ;
Warnock, GL ;
Rajotte, RV ;
SuarezAlmazor, ME ;
Ao, ZL ;
Shapiro, AMJ ;
Kneteman, NM .
TRANSPLANTATION, 1996, 61 (07) :1047-1053
[4]   The use of non-heart-beating donors for isolated pancreatic islet transplantation [J].
Markmann, JF ;
Deng, SP ;
Desai, NM ;
Huang, XL ;
Velidedeoglu, E ;
Frank, A ;
Liu, CY ;
Brayman, KL ;
Lian, MM ;
Wolf, B ;
Bell, E ;
Vitamaniuk, M ;
Doliba, N ;
Matschensky, F ;
Markmann, E ;
Barker, CF ;
Naji, A .
TRANSPLANTATION, 2003, 75 (09) :1423-1429
[5]   Improvement in islet yield from obese donors for human islet transplants [J].
Matsumoto, I ;
Sawada, T ;
Nakano, M ;
Sakai, T ;
Liu, BL ;
Ansite, JD ;
Zhang, HJ ;
Kandaswamy, R ;
Sutherland, DER ;
Hering, BJ .
TRANSPLANTATION, 2004, 78 (06) :880-885
[6]   Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. [J].
Shapiro, AMJ ;
Lakey, JRT ;
Ryan, EA ;
Korbutt, GS ;
Toth, E ;
Warnock, GL ;
Kneteman, NM ;
Rajotte, RV .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (04) :230-238
[7]   Factors affecting human islet of langerhans isolation yields [J].
Toso, C ;
Oberholzer, J ;
Ris, F ;
Triponez, F ;
Bucher, P ;
Demirag, A ;
Andereggen, E ;
Buehler, L ;
Cretin, N ;
Fournier, B ;
Majno, P ;
Hong, Y ;
Lou, J ;
Morel, P .
TRANSPLANTATION PROCEEDINGS, 2002, 34 (03) :826-827
[8]   THE CORRELATION BETWEEN DONOR CHARACTERISTICS AND THE SUCCESS OF HUMAN ISLET ISOLATION [J].
ZENG, YJ ;
TORRE, MA ;
KARRISON, T ;
THISTLETHWAITE, JR .
TRANSPLANTATION, 1994, 57 (06) :954-958